Next Article in Journal
Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery
Next Article in Special Issue
Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
Previous Article in Journal
Antipsoriatic Potential of Quebecol and Its Derivatives
Previous Article in Special Issue
Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(6), 1130; https://doi.org/10.3390/pharmaceutics14061130
Action Date Notes Link
article xml file uploaded 26 May 2022 09:49 CEST Original file -
article xml uploaded. 26 May 2022 09:49 CEST Update -
article pdf uploaded. 26 May 2022 09:49 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1130/pdf-vor
article supplementary file uploaded. 26 May 2022 09:49 CEST - https://www.mdpi.com/1999-4923/14/6/1130#supplementary
article html file updated 26 May 2022 09:50 CEST Original file -
article xml file uploaded 27 May 2022 12:41 CEST Update -
article xml uploaded. 27 May 2022 12:41 CEST Update https://www.mdpi.com/1999-4923/14/6/1130/xml
article pdf uploaded. 27 May 2022 12:42 CEST Updated version of record https://www.mdpi.com/1999-4923/14/6/1130/pdf
article html file updated 27 May 2022 12:43 CEST Update -
article html file updated 3 August 2022 01:52 CEST Update https://www.mdpi.com/1999-4923/14/6/1130/html
Back to TopTop